Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Income from Continuing Operations of 11058000.0 for Q3 2025, up 35.3% year-over-year from 8172992.48 in Q3 2024, and up 16.32% quarter-over-quarter from 13215000.0 in Q2 2025.
Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Income from Continuing Operations for 6 consecutive years, with 11058000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Income from Continuing Operations rose 35.3% year-over-year to 11058000.0; the TTM figure through Sep 2025 stood at 53593000.0 (up 14.12% YoY), while the FY2024 annual figure was 63223000.0, up 11.04% from the prior year.
- Income from Continuing Operations rose to 11058000.0 in Q3 2025 per RBOT's latest filing, from 13215000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 42527000.0 in Q1 2022 and bottomed at 45124000.0 in Q3 2021.
- Historically, Income from Continuing Operations has averaged 10737421.05 across 5 years, with a median of 13926000.0 in 2024.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations plunged 24757.7% — and 2022, when it jumped 912.98%.
- Vicarious Surgical's Income from Continuing Operations stood at 21786000.0 in 2021, then slumped by 151.32% to 11180000.0 in 2022, then slipped by 17.27% to 13111000.0 in 2023, then dropped by 6.22% to 13926000.0 in 2024, then rose by 20.59% to 11058000.0 in 2025.
- Business Quant data shows RBOT's Income from Continuing Operations at 11058000.0 in Q3 2025, 13215000.0 in Q2 2025, and 15394000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vicarious Surgical | 220,312.99 | -14.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | -13.22 Mn |
| Mar 31, 2025 | -15.39 Mn |
| Dec 31, 2024 | -13.93 Mn |
| Sep 30, 2024 | -17.09 Mn |
| Jun 30, 2024 | -15.21 Mn |
| Mar 31, 2024 | -17.00 Mn |
| Dec 31, 2023 | -13.11 Mn |
| Sep 30, 2023 | -15.70 Mn |
| Jun 30, 2023 | -15.33 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -11.18 Mn |
| Sep 30, 2022 | -24.74 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | 42.53 Mn |
| Dec 31, 2021 | 21.79 Mn |
| Sep 30, 2021 | -45.12 Mn |
| Jun 30, 2021 | -6.64 Mn |
| Mar 31, 2021 | -5.23 Mn |
| Dec 31, 2020 | -3.78 Mn |